Regarding "Progression of asymptomatic carotid stenosis despite optimal medical therapy".
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Preventative Health, Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Stroke Division, Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.
Anne
A
Abbott
Department of Vascular Surgery, Imperial College, London, United Kingdom; Department of Vascular Surgery, Ealing Hospital, London, United Kingdom.
George
G
Geroulakos
University College London Medical School, University College London, London, United Kingdom.
Dimitri P
DP
Mikhailidis
Department of Vascular Surgery, Imperial College, London, United Kingdom; Vascular Diagnostic Centre, London, United Kingdom.
Andrew N
AN
Nicolaides
Department of Vascular Surgery, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Henrik
H
Sillesen
Division of Vascular Surgery, The Cleveland Clinic, Cleveland, Ohio; Division of Vascular Surgery, New York University Medical Center, New York, NY.
Frank J
FJ
Veith
D001241:Aspirin / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D016893:Carotid Stenosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
D002317:Cardiovascular Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin